Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anlotinib plus best supportive care vs placebo in metastatic colorectal cancer
CTR20140777Phase 2Active
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anlotinib in colorectal cancer (CRC), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Jul 2015; status: active.
02
Drugs
anlotinib
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on CTR20140777.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140777.